Navigation Links
Jury Rules in Favor of Glycoproducts International, Inc.
Date:5/28/2008

RIGGINS, Idaho, May 28 /PRNewswire/ -- Glycoproducts International, Inc., a provider of nutritional supplement products, today announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated's (Nasdaq: MTEX) patents relating to Mannatech's AMBROTOSE(R) technology.

The jury ruled in favor of Glycoproducts International, Inc., finding that they were innocent of patent infringement of Mannatech's U.S. Patent No. 6,929,807, the parent patent upon which the lawsuit against Glycoproducts International, Inc. was originally based. However, in regard to Mannatech's continuation patent of the parent patent, U.S. Patent No. 7,157,431, which was issued and first claimed to be infringed by Mannatech after the lawsuit was filed, the jury found that Glycoproducts International, Inc. had committed patent infringement.

The jury ruled in favor of Mannatech on its claims of infringement of the AMBROTOSE(R) trademark. Since Glycoproducts International, Inc. successfully defended its position against Mannatech's '807' parent patent, it will oppose Mannatech's request for an injunction to prohibit Glycoproducts International, Inc. from further production, distribution and sale of its Glycomannan(R) product.

Phil Moulton, president of Glycoproducts International, Inc. said, "Our product is distinctly different from Mannatech's products, and is a source of at least 10 of the 11 scientifically recognized biologically vital sugars, with minerals, bioflavonoids and other nutrients that naturally occur within the whole-food matrix."

"Our products are derived from natural sources and are not diluted with rice fillers," he stated.

The verdict was delivered on Friday, May 9, 2008, in the United States District Court for the Northern District of Texas, Dallas Division, following testimony before Federal Magistrate Jeff Kaplan. Glycoproducts International, Inc. (formerly Glycobiotics International, Inc.) was represented by Attorney William G. Shaw, Jr., of Collins, Basinger & Pullman, P.C.


'/>"/>
SOURCE Glycoproducts International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser
2. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
3. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
4. DARA Announces Information in Compliance with NASDAQ Rules
5. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
6. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
7. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
8. When the rules of the game are broken: Research studies sports injuries related to illegal activity
9. IHF Says Google Personal Health-Records System Gives Consumers Greater Control Over Privacy than HIPAA Rules
10. Aetna Requires CAQH Core Rules Certification for Vendors
11. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... 2017 , ... To provide comfort and fuel during the ... category, announces a hearty and wholesome Winter Menu. Starting today, guests can enjoy ... Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage Soup, and ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF ... in Las Vegas, Booth #2809. The SHOT Show is the shooting, hunting and ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... announced the addition of Victor Giamos, MD to their medical staff, according to ... Partner at North Shore Eye Care, a division of SightMD. Dr. Giamos will ...
(Date:1/16/2017)... ... January 16, 2017 , ... St. Louisans are well-aware of the following facts at present:, ... year’s influenza shot seems to be having no effect on keeping this particularly bad strain ... the people around are coughing, sneezing, or sniffling , These facts are ...
(Date:1/16/2017)... ... 2017 , ... One thing common to all types of cancer is that ... well. The money spent screening for and treating cancer in the United States is ... cancer more than in any other country that has an advanced healthcare system, sometimes ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... Transparency Market Research states that the ...  held a huge share of 43% in 2015. Apple Inc., ... the overall market, grabbing the undivided attention of buyers with ... and strong product portfolio is expected to keep these companies ... ...
(Date:1/16/2017)... TORONTO , Jan. 16, 2017  Today, Analytics ... cost-effective medical devices, announced its expansion into JLABS @ ... Johnson Innovation,s life science incubators. As a resident in ... of cardiovascular medical device development and commercialization expertise. ... a life science innovation center that provides a flexible ...
(Date:1/15/2017)... January 16, 2017 Der Vorstand ... für die Regeneration des menschlichen Gewebes, gibt die Ernennung ... sofortiger Wirkung bekannt. ... Bill Allan ist ... bekleidete eine Reihe von Geschäftsführer- und anderen Führungspositionen bei ...
Breaking Medicine Technology: